Glaukos Corporation announced that the US Centers for Medicare and Medicaid Services (CMS) has assigned a permanent ...
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, ...
Zacks Investment Research on MSN
Glaukos wins permanent J-code for Epioxa keratoconus therapy
Glaukos GKOS announced that its innovative keratoconus treatment, Epioxa (Epioxa HD / Epioxa), was assigned a permanent HCPCS ...
Stocktwits on MSN
OMER stock on track for best week in nearly 4 months after receiving permanent reimbursement code for treatment
The company said the move reduces administrative hurdles by facilitating easier claims processing for hospitals and clinics. ・Yartemlea is the first and only FDA-approved medicine for hematopoietic ...
NORTHBROOK, Ill., March 26, 2024 /PRNewswire/ -- Iveric Bio, An Astellas Company (TSE: 4503, President and CEO: Naoki Okamura, "Astellas"), today announced the U.S. Centers for Medicare and Medicaid ...
East Brunswick’s Savient Pharmaceuticals Inc. is starting the new year with a major boost. Savient’s chronic gout drug, Krystexxa, now has its own permanent billing code from the Centers for Medicare ...
Pacira BioSciences (NASDAQ:PCRX) on Thursday announced that the U.S. Centers for Medicare and Medicaid Services (CMS) issued a product-specific J-code for its non-opioid pain therapy Exparel for ...
The aflibercept 8 mg injection improves patient care by allowing longer intervals between treatments, explains Jose A. Martinez, MD, Austin Retina Associates. A new Healthcare Common Procedure Coding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results